Compare
Evolent Health, Inc. vs Gartner Inc vs Franklin Covey Co
| Latest fiscal year | Evolent Health, Inc. EVH | Gartner Inc IT | Franklin Covey Co FC |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-08-31 |
| Revenue | $1.88B | $6.50B | $267.07M |
| Revenue growth (YoY) | -26.6% | +3.7% | -7.0% |
| Gross margin | 21.3% (computed) | 68.8% | 76.2% |
| Operating margin | -21.9% | 15.8% | 2.1% |
| Net margin | -28.5% | 11.2% | 1.1% |
| Net income | -$534.51M | $729.23M | $3.07M |
| EPS (Diluted) | -$5.07 | $9.65 | $0.24 |
| Operating cash flow | $38.84M | $1.29B | $28.98M |
| Free cash flow | n/a | n/a | $20.72M |
| Cash & equivalents | $151.86M | $1.72B | $31.70M |
| Total assets | $1.90B | $8.09B | $242.91M |
| Total liabilities | $1.48B | $7.77B | $176.00M |
| Shareholders' equity | $415.19M | $319.91M | $66.91M |
| Return on year-end equity | -128.7% | 228.0% | 4.6% |
| Shares outstanding | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Evolent Health, Inc. | Gartner Inc | Franklin Covey Co |
|---|---|---|---|
| Latest | $1.88B Ended 2025-12-31 | $6.50B Ended 2025-12-31 | $267.07M Ended 2025-08-31 |
| 1 year earlier | $2.55B Ended 2024-12-31 | $6.27B Ended 2024-12-31 | $287.23M Ended 2024-08-31 |
| 2 years earlier | $1.96B Ended 2023-12-31 | $5.91B Ended 2023-12-31 | $280.52M Ended 2023-08-31 |
| 3 years earlier | $1.35B Ended 2022-12-31 | $5.48B Ended 2022-12-31 | $262.84M Ended 2022-08-31 |
| 4 years earlier | $907.96M Ended 2021-12-31 | $4.73B Ended 2021-12-31 | $224.17M Ended 2021-08-31 |